Literature DB >> 16901076

Pathogenesis of idiopathic inflammatory myopathies.

Cecilia Grundtman, Ingrid E Lundberg.   

Abstract

The idiopathic inflammatory myopathies, myositis, are characterized by a chronic course with decreased muscle endurance and by infiltrates of T lymphocytes and macrophages in muscle tissue. Treatment with immunosuppressives rarely leads to recovery of muscle function, despite abolishment of inflammatory cell infiltrates in muscle tissue. Therefore, other mechanisms than immune-mediated muscle fiber damage are likely to contribute to the pathogenesis. One such non-immune-mediated muscle dysfunction could be caused by a disturbed microcirculation due to capillary loss or to phenotypically changed endothelial cells in the capillaries. These aberrations may affect the micro-environment of muscle tissue and lead to local tissue hypoxia with development of a secondary metabolic myopathy. Another possible non-immune-mediated mechanism leading to muscle dysfunction is the newly identified endoplasmatic reticulum (ER) stress response in myositis. The ER stress response is thought to be a consequence of the up-regulation of major histocompatibility complex class I in muscle fibers. These newly identified molecular pathways could play a major role in the pathogenesis of myositis and could be important targets in the development of new therapies.

Entities:  

Mesh:

Year:  2006        PMID: 16901076     DOI: 10.1007/s11926-996-0024-4

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  50 in total

1.  Expression of specific matrix metalloproteinases in inflammatory myopathies.

Authors:  B C Kieseier; C Schneider; J M Clements; A J Gearing; R Gold; K V Toyka; H P Hartung
Journal:  Brain       Date:  2001-02       Impact factor: 13.501

2.  Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies.

Authors:  K Murata; M C Dalakas
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

3.  Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies.

Authors:  A M Emslie-Smith; K Arahata; A G Engel
Journal:  Hum Pathol       Date:  1989-03       Impact factor: 3.466

4.  A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli.

Authors:  K Nagaraju; N Raben; G Merritt; L Loeffler; K Kirk; P Plotz
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

5.  Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.

Authors:  I Lundberg; A K Ulfgren; P Nyberg; U Andersson; L Klareskog
Journal:  Arthritis Rheum       Date:  1997-05

6.  Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis.

Authors:  P Nyberg; A L Wikman; I Nennesmo; I Lundberg
Journal:  J Rheumatol       Date:  2000-04       Impact factor: 4.666

7.  Expression of human IAP-like protein in skeletal muscle: a possible explanation for the rare incidence of muscle fiber apoptosis in T-cell mediated inflammatory myopathies.

Authors:  M Li; M C Dalakas
Journal:  J Neuroimmunol       Date:  2000-07-01       Impact factor: 3.478

8.  Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls.

Authors:  I Lundberg; J M Brengman; A G Engel
Journal:  J Neuroimmunol       Date:  1995-12       Impact factor: 3.478

9.  Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies.

Authors:  J van der Pas; G J D Hengstman; H J ter Laak; G F Borm; B G M van Engelen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-01       Impact factor: 10.154

10.  Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells.

Authors:  O M Zack Howard; Hui Fang Dong; De Yang; Nina Raben; Kanneboyina Nagaraju; Antony Rosen; Livia Casciola-Rosen; Michael Härtlein; Michael Kron; David Yang; Kwabena Yiadom; Sunita Dwivedi; Paul H Plotz; Joost J Oppenheim
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more
  6 in total

1.  Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand.

Authors:  Peter Szodoray; Philip Alex; Nicholas Knowlton; Michael Centola; Igor Dozmorov; Istvan Csipo; Annamaria T Nagy; Tamas Constantin; Andrea Ponyi; Britt Nakken; Katalin Danko
Journal:  Rheumatology (Oxford)       Date:  2010-06-29       Impact factor: 7.580

2.  Abnormal paraoxonase-1 (PON1) enzyme activity in idiopathic inflammatory myopathies.

Authors:  Sangmee Sharon Bae; Ani Shahbazian; Jennifer Wang; Ilana Golub; Buzand Oganesian; Tyler Dowd; Beata Vayngortin; Ryan Wang; David Elashoff; Srinivasa T Reddy; Christina Charles-Schoeman
Journal:  Rheumatology (Oxford)       Date:  2022-05-30       Impact factor: 7.046

Review 3.  Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.

Authors:  E M Moran; F L Mastaglia
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

4.  Pretreatment with a soluble activin type IIB receptor/Fc fusion protein improves hypoxia-induced muscle dysfunction.

Authors:  Emidio E Pistilli; Sasha Bogdanovich; Matias Mosqueira; Jennifer Lachey; Jasbir Seehra; Tejvir S Khurana
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-10-28       Impact factor: 3.619

5.  Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women.

Authors:  Lori A Love; Clarice R Weinberg; D Robert McConnaughey; Chester V Oddis; Thomas A Medsger; John D Reveille; Frank C Arnett; Ira N Targoff; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2009-08

Review 6.  Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies.

Authors:  Cecilia Grundtman; Vivianne Malmström; Ingrid E Lundberg
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.